The stock remains halted with no trading activity, making this filing purely informational for existing holders. The widening net loss and cash burn confirm the operational deterioration flagged in the FY2025 20-F. Regulatory approvals for PVRV-SF and HFMD2 are positive pipeline catalysts but do not address the immediate liquidity or governance issues. Monitor the Antigua legal proceedings regarding the 2018 PIPE shares and any Nasdaq delisting developments.
Price Chart
Executive Summary
Sinovac reported H1 2026 unaudited results: sales grew 12.9% YoY to $147.1M, driven by 82.3% overseas revenue growth, but net loss attributable to common shareholders widened to -$60.2M (-$0.84/share) from -$21.7M (-$0.30/share) a year ago, as other income collapsed from $161.9M to $21.1M and operating cash burn deepened to -$321.8M. The filing also highlights two key regulatory milestones post-period: NMPA approval of the rabies vaccine PVRV-SF and priority review acceptance of the HFMD2 NDA. Combined with the prior 20-F showing deep operational deterioration and a halted stock since Feb 2019, this filing confirms persistent losses and governance overhang with no path to trading resumption.
Key Facts
- H1 2026 sales $147.1M (+12.9% YoY) vs $130.3M in H1 2025.
- Net loss attributable to common shareholders widened to -$60.2M (-$0.84/share) from -$21.7M (-$0.30/share).
- Other income, net collapsed to $21.1M from $161.9M, primarily due to lower investment income and higher FX losses.
- Operating cash flow used -$321.8M vs -$267.9M in prior year period.
- Cash and restricted cash fell to $998.5M from $1.2B at Dec 31, 2025.
- PVRV-SF (rabies vaccine) received NMPA marketing approval on Aug 4, 2026; HFMD2 NDA accepted for priority review on July 10, 2026.
- Trading remains halted since Feb 2019; stock has no active market.
- Prior 20-F (June 5, 2026) showed FY2025 net loss -$59.7M vs +$90.9M profit in 2024, with massive impairments and a $3.96B dividend upstream.
Financial Impact
Net loss attributable to common shareholders worsened by $38.5M YoY to -$60.2M; operating cash burn increased by $53.9M to -$321.8M; cash reserves declined by $157.9M to $998.5M.
Risk Factors
- Persistent net losses and negative operating cash flow may further erode cash reserves.
- Stock remains halted since Feb 2019 with no clear path to trading resumption.
- Ongoing Antigua legal proceedings over 11.8M disputed PIPE shares create governance uncertainty.
- Material weaknesses in internal controls persist per prior 20-F.
- Dividend payable of $657.2M remains a large current liability.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (SVA) — Batch item 1 | 0001193125-26-353263 |
| Document: sinovac_-_fy2026h1_pr.htm | 0001193125-26-353263 |
| Document: 0001193125-26-353263-index-headers.html | 0001193125-26-353263 |
| Document: 0001193125-26-353263-index.html | 0001193125-26-353263 |
| Document: 0001193125-26-353263.txt | 0001193125-26-353263 |
| 6-K Filing (SVA) — Batch item 6 | 0001193125-26-353263 |
| Document: sinovac_-_fy2026h1_pr.htm | 0001193125-26-353263 |
| Document: 0001193125-26-353263-index-headers.html | 0001193125-26-353263 |
| Document: 0001193125-26-353263-index.html | 0001193125-26-353263 |
| Document: 0001193125-26-353263.txt | 0001193125-26-353263 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 10w ago | 6-K | — | awaiting T+5 | — | — |
Jul 15, 2026 14w ago | 6-K | — | awaiting T+5 | — | — |
Jun 15, 2026 19w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −2.62% | — |
Jun 5, 2026 20w ago | 20-F | $6.47 $6.47 | · 0.00% | ▲ +0.57% | — |
May 29, 2026 21w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −2.75% | — |
May 21, 2026 22w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −1.85% | — |
May 8, 2026 24w ago | 6-K | $6.47 $6.47 | · 0.00% | ▼ −0.09% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers